Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Kempharm, Inc
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Kempharm, Inc since year 2005.
Table 2 shows the detailed insider transactions of Kempharm, Inc since 2005.
The reporting company's ticker symbol is KMPH. The reporting company's CIK number is 1434647.
The total value of stock buying since 2005 is $1,385,654.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $61,998.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2017-11-27||Cohen Daniel L (EVP, Govt. & Public Relations)||Buy||7,500||3.77||28,312|
|2017-09-25||Clifton R. Laduane (CFO, Secretary & Treasurer)||Buy||300||3.77||1,132|
|2017-09-14||Bluhm Andrew G (10% Owner)||Buy||138,857||3.30||458,644|
|2017-09-13||Bluhm Andrew G (10% Owner)||Buy||187,031||3.25||608,037|
|2017-08-24||Cohen Daniel L (EVP, Govt. & Public Relations)||Buy||5,000||2.58||12,880|
|2017-08-24||Johnson Gordon K (Chief Business Officer)||Buy||4,000||2.60||10,388|
|2017-06-20||Mickle Travis C (President & CEO)||Buy||8,000||3.45||27,592|
|2017-06-19||Clifton R. Laduane (CFO, Secretary & Treasurer)||Buy||275||3.30||907|
|2017-05-25||Cohen Daniel L (EVP, Govt. & Public Relations)||Buy||2,500||4.12||10,305|
|2017-03-31||Cohen Daniel L (EVP, Govt. & Public Relations)||Buy||1,000||4.70||4,700|
|2017-03-29||Cohen Daniel L (EVP, Govt. & Public Relations)||Buy||1,500||4.33||6,502|
|2017-03-24||Clifton R. Laduane (CFO, Secretary & Treasurer)||Buy||1,000||4.24||4,244|
|2017-03-22||Mickle Christal M M (VP, Operations & Product Dvlp.)||Buy||2,000||4.10||8,200|
|2017-03-22||Mickle Travis C (President & CEO)||Buy||2,000||4.10||8,200|
|2017-03-20||Tierney David S (Director)||Buy||1,000||4.20||4,200|
|2016-11-30||Cohen Daniel L (EVP, Govt and Public Relations)||Buy||5,000||3.49||17,440|
|2016-09-06||Cohen Daniel L (EVP, Govt and Public Relations)||Buy||3,690||5.01||18,490|
|2016-09-02||Cohen Daniel L (EVP, Govt and Public Relations)||Buy||6,310||4.59||28,981|
|2016-08-17||Mickle Christal M M (VP Prod Dev)||Buy||5,000||4.95||24,750|
|2016-08-17||Mickle Travis C (President & CEO)||Buy||5,000||4.95||24,750|
|2016-04-04||Thompson Danny L (Director)||Option Ex||13,333||4.65||61,998|
|2015-04-21||Johnson Gordon K (COO & CFO)||Buy||2,000||11.00||22,000|
|2015-04-21||Tierney David S (Director)||Buy||5,000||11.00||55,000|
Insider trading activities including stock purchases, stock sales, and option exercises of KMPH listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Kempharm, Inc (symbol KMPH, CIK number 1434647) see the Securities and Exchange Commission (SEC) website.